| Literature DB >> 7577478 |
R V Iaffaioli1, A Tortoriello, G Facchini, M Santangelo, G De Sena, G Gesue, L Bucci, G Scaramellino, E Anastasio, A Finizio.
Abstract
Forty-one patients with advanced breast cancer were given carboplatin and vinorelbine as second-line therapy. Overall objective response rate was 46% (95% confidence interval 26-56%). Myelotoxicity was the most frequently observed toxic effect; grade III-IV leucopenia occurred in 46% of the patients. Our regimen is active as second-line chemotherapy for advanced breast cancer and warrants further evaluation.Entities:
Mesh：
Substances：
Year: 1995 PMID： 7577478 PMCID： PMC2033957 DOI： 10.1038/bjc.1995.496
Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640